Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

434 public trials 103 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Completed

Phase II Study of 5-FU, Oxaliplatin Plus Dasatinib in Metastatic Pancreatic Adenocarcinoma

NCT01652976

Conditions: Adenocarcinoma, Carcinoma, Digestive System Diseases, +14 more
Locations: UF Health Cancer Center Gainesville, Florida, United States

View Trial Details

Completed

Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung Cancers

NCT01579994

Conditions: Adenocarcinoma, Advanced Lung Cancer, Carcinoma, +7 more
Locations: Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States

Memorial Sloan Kettering Cancer Center New York, United States

Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States

View Trial Details

Completed

Study of Onivyde and 5-FU in Combination With Xilonix for Pancreatic Cancer With Cachexia

NCT03207724

Conditions: Adenocarcinoma, Body Weight, Body Weight Changes, +19 more
Locations: Cedars-Sinai Medical Center Los Angeles, California, United States

View Trial Details

Completed

Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer Patients

NCT01487785

Conditions: Adenocarcinoma, Carcinoma, Digestive System Diseases, +10 more
Locations: Massachusetts General Hospital Dept. of Mass General Hospital Boston, Massachusetts, United States

Memorial Sloan Kettering Cancer Center MSKCC - SC New York, United States

University of Utah / Huntsman Cancer Institute Huntsman UT Salt Lake City, Utah, United States

Novartis Investigative Site Barcelona, Catalonia, Spain

View Trial Details

Completed

MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal Adenocarcinoma

NCT01443065

Conditions: Adenocarcinoma, Carcinoma, Digestive System Diseases, +14 more
Locations: Institut Gustave Roussy Villejuif, France

View Trial Details

Completed

Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer

NCT01295086

Conditions: Adenocarcinoma, Carcinoma, Neoplasms, +2 more
Locations: Aalborg University Hospital Aalborg, Denmark

Aarhus University Hospital Aarhus, Denmark

Rigshospitalet Copenhagen, Denmark

Odense University Hospital Odense, Denmark

View Trial Details

Completed

SOM 230 and Gemcitabine in Advanced Pancreatic Cancer

NCT01385956

Conditions: Adenocarcinoma, Carcinoma, Digestive System Diseases, +14 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer

NCT01616303

Conditions: Adenocarcinoma, Adnexal Diseases, Carcinoma, +16 more
Locations: University of Connecticut Health Center Farmington, Connecticut, United States

Northern Indiana Cancer Research Consortium South Bend, Indiana, United States

View Trial Details

Completed

Trial of Curcumin in Advanced Pancreatic Cancer

NCT00094445

Conditions: Adenocarcinoma, Carcinoma, Digestive System Diseases, +9 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

A Data Collection Study for Patients With Adenocarcinoma Treated With the MyVaccx Immunotherapy Regimen.

NCT03695835

Conditions: Adenocarcinoma, Carcinoma, Colonic Diseases, +35 more
Locations: The Center for High Risk and Recurrent Prostate Cancer Fort Lauderdale, Florida, United States

View Trial Details

Adenocarcinoma

Adenocarcinoma trial results

Related conditions